Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFoxtons Regulatory News (FOXT)

Share Price Information for Foxtons (FOXT)

Share Price is delayed by 15 minutes
Get Live Data
44.60    -0.50 (-1.11%)
Bid:
44.60
Ask:
45.35
Spread: 0.75 (1.682%)
Market Cap: £131.88m
FOXT Live PriceLast checked at - London Stock Exchange

Intraday Foxtons Share Chart

Trading Statement

30 Jan 2020 07:00

RNS Number : 3444B
Foxtons Group PLC
30 January 2020
 

FOXTONS GROUP PLC

UNAUDITED FULL YEAR TRADING UPDATE

Thursday 30 January 2020

Foxtons Group plc (LSE: FOXT), London's leading estate agency, today issues its unaudited full year trading update for the year ended 31 December 2019.

Group revenue for the full year was circa £107m, down 4% on the prior year (2018: £111.5m). This robust performance in difficult market conditions was due to improved Sales market share and growth in revenues from landlords.

Including the impact of the tenant fee ban (£2.7m), Lettings revenue fell 2% to circa £66m (2018: £67m), driven by our decision not to increase fees in response to the ban. Revenue from landlords continued to benefit from the wide-ranging improvements we have made to our Lettings offer.

Sales revenue fell by 10% to circa £33m (2018: £36m) as transaction volumes were impacted by ongoing political uncertainty, particularly at the higher end of the market.

Mortgage revenue grew by 3%, with strong growth in re-mortgages outweighing lower new mortgage volumes.

During December, Foxtons closed four underperforming branches whose territories can be well served by other branches in the Foxtons network; additionally, Foxtons has taken an impairment charge on a number of low profitability branches. Together these will result in a one-off charge of around £6m in 2019, the vast majority of which is non-cash.

The resilient revenue performance, including a stronger end to the year, combined with continued control of operating costs means Adjusted EBITDA1 post-IFRS 16 is expected to be in the range £13.0m to £13.5m (Adjusted EBITDA pre-IFRS 16 £2.0m to £2.5m). The Group's cash balance at the end of the year was £15.5m (2018: £17.9m).

Foxtons intends to issue its full year results on 28 February 2020.

Nic Budden, CEO, said:

"Our team should feel pleased to have delivered a solid performance in difficult market conditions as political uncertainty played a significant role in suppressing an already weak sales market. Looking forward, with the uncertainty of the general election removed, early signs are that the sales market may improve during 2020 and our sales pipeline is ahead of last year. It is, however, too early to predict how the market will behave during the year with structural issues like affordability and stamp duty continuing to act as a brake on sales volumes. Competition in the lettings market remains fierce. Overall though Foxtons has successfully navigated a very difficult period and is well placed to benefit from any lasting improvement in market conditions."

 

For further information, please contact:

Foxtons Group plc

Richard Harris, Chief Financial Officer

Muhammad Patel, Investor Relations

+44 20 7893 6261

investor@foxtonsgroup.co.uk

Teneo

Robert Morgan / Anthony Di Natale

+44 20 7420 3194

 

1 Adjusted EBITDA is defined by the Group as profit before tax, finance costs, finance income, other gains/losses, depreciation, amortisation, profit on disposal of fixed assets, share‐based payments and Adjusted items.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFVRLEIAFII
Date   Source Headline
10th May 20193:48 pmRNSHolding(s) in Company
9th May 201911:50 amRNSHolding(s) in Company
7th May 20194:07 pmRNSHolding(s) in Company
28th Mar 20197:00 amRNSAnnual Financial Report
19th Mar 20199:32 amRNSHolding(s) in Company
15th Mar 201910:28 amRNSHolding(s) in Company
8th Mar 20199:06 amRNSHolding(s) in Company
1st Mar 20199:27 amRNSHolding(s) in Company
28th Feb 20197:00 amRNSFinal Results
27th Feb 20195:59 pmRNSHolding(s) in Company
21st Feb 20193:39 pmRNSHolding(s) in Company
20th Feb 20195:12 pmRNSHolding(s) in Company
15th Feb 20199:28 amRNSHolding(s) in Company
12th Feb 20195:08 pmRNSHolding(s) in Company
1st Feb 20193:37 pmRNSHolding(s) in Company
1st Feb 20199:41 amRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading Update
28th Jan 20194:00 pmRNSAndrew Adcock
14th Jan 20193:36 pmRNSHolding(s) in Company
11th Jan 20193:57 pmRNSHolding(s) in Company
11th Jan 20199:34 amRNSHolding(s) in Company
9th Jan 20195:26 pmRNSHolding(s) in Company
8th Jan 20199:22 amRNSHolding(s) in Company
3rd Jan 20193:52 pmRNSHolding(s) in Company
2nd Jan 20194:00 pmRNSHolding(s) in Company
2nd Jan 201910:22 amRNSHolding(s) in Company
20th Dec 20184:35 pmRNSPrice Monitoring Extension
6th Dec 20184:35 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSTrading Update
6th Nov 201810:16 amRNSHolding(s) in Company
2nd Nov 20182:54 pmRNSHolding(s) in Company
2nd Nov 20181:07 pmRNSHolding(s) in Company
2nd Nov 201812:06 pmRNSHolding(s) in Company
31st Jul 201811:52 amRNSHolding(s) in Company
30th Jul 20187:00 amRNSHalf-year Report
27th Jul 20184:58 pmRNSHolding(s) in Company
19th Jul 20184:55 pmRNSHolding(s) in Company
19th Jul 20182:51 pmRNSHolding(s) in Company
18th Jul 20185:11 pmRNSHolding(s) in Company
18th Jun 20185:02 pmRNSDirectorate Change
17th May 20181:26 pmRNSResult of AGM
17th May 20187:00 amRNSTrading Update
5th Apr 201812:30 pmRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSAnnual Financial Report
28th Feb 20187:00 amRNSFinal Results
25th Jan 20187:00 amRNSTrading Update for year ended 31 December 2017
18th Jan 201812:18 pmRNSHolding(s) in Company
2nd Nov 20175:19 pmRNSHolding(s) in Company
2nd Nov 20175:10 pmRNSHolding(s) in Company
18th Oct 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.